Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 9, Pages 2061
Publisher
MDPI AG
Online
2022-04-21
DOI
10.3390/cancers14092061
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
- (2022) Jin-Cui Yang et al. Frontiers in Oncology
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
- (2021) Ismail Labgaa et al. Cancers
- Current status of ctDNA in precision oncology for hepatocellular carcinoma
- (2021) Yan Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors
- (2021) Bardia Yousefi et al. Scientific Reports
- Tri‐modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell‐free DNA using machine learning algorithm
- (2021) Jiyoon Bu et al. Clinical and Translational Medicine
- Immunoavidity-Based Capture of Tumor Exosomes Using Poly(amidoamine) Dendrimer Surfaces
- (2020) Michael J. Poellmann et al. NANO LETTERS
- Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application
- (2020) Jiyoon Bu et al. BIOSENSORS & BIOELECTRONICS
- Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
- (2020) Johann von Felden et al. ONCOGENE
- TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma
- (2020) Stine K. Oversoe et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Viable and high-throughput isolation of heterogeneous circulating tumor cells using tapered-slit filters
- (2020) Jae-Eul Shim et al. SENSORS AND ACTUATORS B-CHEMICAL
- Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer
- (2020) Jiyoon Bu et al. PLoS One
- Exosomes in hepatocellular carcinoma: a new horizon
- (2019) Rui Chen et al. Cell Communication and Signaling
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
- (2019) Jessica Howell et al. EUROPEAN JOURNAL OF CANCER
- Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
- (2019) Qianwei Ye et al. Molecular Cancer
- Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study
- (2019) Ilaria Alborelli et al. Cell Death & Disease
- Multi-modal liquid biopsy platform for cancer screening: screening both cancer-associated rare cells and cancer cell-derived vesicles on the fabric filters for a reliable liquid biopsy analysis
- (2019) Jiyoon Bu et al. Nano Convergence
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
- (2018) Naoto Fujiwara et al. JOURNAL OF HEPATOLOGY
- Bioorthogonal DNA Adsorption on Polydopamine Nanoparticles Mediated by Metal Coordination for Highly Robust Sensing in Serum and Living Cells
- (2018) Yingcai Meng et al. ACS Nano
- Liquid biopsy for liver diseases
- (2018) Jelena Mann et al. GUT
- Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
- (2018) Jean-Luc Raoul et al. CANCER TREATMENT REVIEWS
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma
- (2017) Reetta Holmila et al. PLoS One
- Circulating tumor cells in the differential diagnosis of adnexal masses
- (2017) Dong Hoon Suh et al. Oncotarget
- Enhancement of isolation sensitivity for the viable heterogeneous circulating tumor cells swelled by hypo-osmotic pressure
- (2017) Jiyoon Bu et al. RSC Advances
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Heterogeneity of liver cancer and personalized therapy
- (2016) Liang Li et al. CANCER LETTERS
- TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
- (2016) J. J. Wheler et al. MOLECULAR CANCER THERAPEUTICS
- Molecular Pathogenesis of Hepatocellular Carcinoma
- (2016) Daniel Wai-Hung Ho et al. Liver Cancer
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
- (2013) Tiffany Hennedige et al. CANCER IMAGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started